New EU Commission Recommendation for PPE and Medical Devices – COVID-19
PPE and Medical Devices have proven to be essential for healthcare workers in the efforts to contain the COVID-19 outbreak. In March 2020, the EU Commission urged the economic operators to increase rapid supply into the market. Currently, the Commission considers that the conditions for exceptional access to market are no longer met, limiting the placing of PPE and Medical Devices which have not successfully undergone the relevant conformity assessment procedures applicable on the EU market.


In March 2020, the European Commission adopted Recommendation (EU) 2020/403 on conformity assessment and market surveillance procedures within the context of the COVID-19 outbreak. The aim was to allow for the increased supply of Personal Protective Equipment (PPE) and Medical Devices to feed into the market rapidly and without undue delays.

Accordingly, if market surveillance authorities found that conformity assessment procedures (including affixing of CE marking) were not yet finalized, but the PPE or medical device ensured an adequate level of health and safety, they could authorize the making available of such products on the EU market, for a limited period of time and while the necessary procedures were being carried out.

Moreover, PPE or medical devices without CE marking could also be assessed and part of a purchase organized by the relevant Member States. This was merely possible if these products were only available for healthcare workers for the duration of the health crisis and if they were not entering the regular distribution channels and made available for other users.

There was an unprecedented and exponential growth in the demand for medical devices and for PPE, like face masks, gloves, and others. Following this recommendation, EU Economic operators have worked hard on increasing their manufacturing and distribution capacity in order to answer the increased demand, redesigning their supply chains, launching new manufacturing lines and diversifying their supplier base.


In this new Recommendation on conformity assessment and market surveillance procedures within the context of the COVID-19 threat, the Commission concluded, based on information provided by industrial stakeholders and relevant national authorities, that there are no longer any significant shortages of PPE and medical devices on the European market, and it is to be expected that the situation would remain stable. The Commission considers that the underlying conditions justifying the application of Recommendation (EU) 2020/403 are no longer reunited.

Regulation (EU) 2016/425 lays down the requirements for the design, manufacturing and placing on the market of PPE. Particle filtering half-masks, coveralls and eyewear protection fall within the scope of this Regulation.

As for medical devices, such as surgical masks, examination gloves and some types of gowns, the requirements for design, manufacturing and placing on the market are laid down by Regulation (EU) 2017/745.

As happened before the Recommendation (EU) 2020/403, when a manufacturer wants to place a PPE or medical device on the market, it should carry out the applicable conformity assessment procedures and affix the CE marking, if compliance with applicable requirements has been demonstrated by the appropriate procedure. Annex II to Regulation (EU) 2016/245 for PPE and Annex I to Regulation (EU) 2017/745 for medical devices sets the essential performance and safety requirements that these products shall meet so they can be placed on the market and circulate freely across the entire EU market.

PPE and medical devices that were assessed by market surveillance authorities and granted approval decision (according to mechanisms described in point 7 and 8 of Recommendation (EU) 2020/403), have been proven to comply with essential health and safety requirements of Regulation (EU) 2016/425 and Regulation (EU) 2017/745).

The Commission has set a date from which no PPE or medical devices should be made available on the EU market unless it has undergone the mandatory conformity assessment procedures and has been lawfully affixed with the CE marking.

As from 1 October 2021, PPE that have not been successfully undergone the relevant conformity assessment procedures (in accordance with PPE Regulation (EU) 2016/425) should no longer be authorized by market surveillance authorities and cannot be placed on the EU market.

PPE or medical devices that have been granted authorization according to Recommendation (EU) 2020/403 can only be made available until 31 May 2022. Exception is made for products that are part of existing stocks at the disposal of healthcare workers, first responders and other personnel involved in the efforts to contain the virus and avoid its further spread. These stocks may be made available until fully exhausted, but no later than 31 July 2022.

From 1 August 2022, market surveillance authorities should ensure that all PPE or medical devices placed in the EU market have successfully passed the relevant conformity assessment procedures in accordance with Regulation (EU) 2016/245 and Regulation (EU) 2017/745 and bear a lawfully affixed CE marking. For medical devices, such does not apply if specific derogations from the conformity assessment procedure have been authorized by Member States, according to the corresponding Regulation.


  1. Commission Recommendation (EU) 2021/1433 of 1 September 2021 on conformity assessment and market surveillance procedures within the context of the COVID-19 threat.
  2. Commission Recommendation (EU) 2020/403 of 13 March 2020 on conformity assessment and market surveillance procedures within the context of the COVID-19 threat.
  3. Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC.
  4. Regulation (EU) 2016/425 of the European Parliament and of the Council of 9 March 2016 on personal protective equipment and repealing Council Directive 89/686/EEC.


medical devices

EUDAMED – harmonized practices and alternative solutions for IVDR until the database is fully functional

EUDAMED is one of the key aspects of the new rules on in vitro diagnostic medical devices – Regulation (EU) 2017/746. However, it is only expected to achieve full functionality by the second quarter of 2024. Until then, how is the information submitted and/or exchanged between manufacturers, notified bodies and competent authorities?

Read More »
medical devices

EUDAMED – update on timelines

EUDAMED is one of the key aspects of the new rules on medical devices (Regulation (EU) 2017/745) and in vitro diagnostic medical devices (Regulation (EU) 2017/746), and it is expected to achieve full functionality by the second quarter of 2024.

Read More »
cosmetic products

UK OPSS call for data on six cosmetic ingredients

On 14 July 2022, the Office for Product Safety and Standards (OPSS – the UK regulator for cosmetic products) issued a call for data on the safety of the following six cosmetic ingredients to investigate any suspected endocrine disrupting properties. 

Read More »
cosmetic products

European Commission Recommendation on the Definition of Nanomaterial

Nanomaterials are increasingly used in cosmetics and personal care products. They are similar to other chemicals/substances, but with specific risks associated to their use. The European Commission has published a new Recommendation to clarify the definition of ‘nanomaterial’. This definition may serve different policy, legislative and research purposes when addressing materials or issues concerning products of nanotechnologies.

Read More »
cosmetic products

Expected Restriction on the Use of Methyl Salicylate

The European Commission has notified the World Trade Organization (WTO) of a draft amendment to the Regulation (EC) No. 1223/2009 on cosmetic products. Annex III to Regulation will be amended, and the use of Methyl Salicylate in cosmetic products will be restricted.

Read More »
cosmetic products

Environmental Labelling of Cosmetic Products in Italy and France

Although the European Cosmetics Regulation is applicable to every cosmetic product made available in the European Union market, some national legislations may also apply. Environmental regulations in Italy and France specify mandatory labelling requirements applicable to products marketed in these countries.

Read More »